| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25021-239-52 | 25021-239 | HUMAN PRESCRIPTION DRUG | Gemcitabine | gemcitabine | INJECTION, SOLUTION | INTRAVENOUS | 20190115 | N/A | ANDA | ANDA209077 | Sagent Pharmaceuticals | GEMCITABINE HYDROCHLORIDE | 38 mg/mL | 1 VIAL in 1 CARTON (25021-239-52) / 52.6 mL in 1 VIAL |
| 25021-239-26 | 25021-239 | HUMAN PRESCRIPTION DRUG | Gemcitabine | gemcitabine | INJECTION, SOLUTION | INTRAVENOUS | 20190115 | N/A | ANDA | ANDA209077 | Sagent Pharmaceuticals | GEMCITABINE HYDROCHLORIDE | 38 mg/mL | 1 VIAL in 1 CARTON (25021-239-26) / 26.3 mL in 1 VIAL |
| 25021-239-05 | 25021-239 | HUMAN PRESCRIPTION DRUG | Gemcitabine | gemcitabine | INJECTION, SOLUTION | INTRAVENOUS | 20190115 | N/A | ANDA | ANDA209077 | Sagent Pharmaceuticals | GEMCITABINE HYDROCHLORIDE | 38 mg/mL | 1 VIAL in 1 CARTON (25021-239-05) / 5.26 mL in 1 VIAL |